ArticleBiomolecules2024

IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy.

Ioannis M Koukourakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.